Principal Investigator Ian Hunter
The laboratory's Needle Free Injector (NFI) utilizing a custom, controllable linear Lorentz-force motor (among a suite of other technologies) will allow for repeatable delivery of drug to a target tissue via jet injection. Current research is directed toward evaluating the feasibility of delivering vaccines and biotherapeutics to a variety of target tissues and organs.